Related Experiment Video
Updated: Mar 31, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
20.7K
Iron Chelation in Thalassemia Major.
Caterina Borgna-Pignatti1, Maria Marsella2
1Department of Medical Sciences, Section of Pediatrics, University of Ferrara, Ferrara, Italy.
Clinical Therapeutics
|November 1, 2015
Summary
Iron chelation therapy is vital for thalassemia major patients. Tailoring treatment with available chelators, guided by MRI, improves outcomes and reduces complications. Further research is needed for optimal patient care.
Area of Science:
- Hematology
- Pharmacology
- Medical Treatment
Background:
- Thalassemia major management relies on iron chelation to improve survival and quality of life.
- Three distinct iron-chelating drugs are available, each with unique pharmacokinetic and pharmacodynamic properties.
- Personalized treatment selection is essential, guided by current scientific evidence.
Purpose of the Study:
- To review the current landscape of iron chelation therapy for thalassemia major.
- To highlight the importance of tailoring treatment based on individual patient needs and drug characteristics.
- To emphasize the role of scientific evidence in guiding therapeutic choices.
Main Methods:
- A comprehensive literature review was conducted, focusing on recent scientific publications.
- Analysis of pharmacokinetic and pharmacodynamic data of available iron chelators.
- Evaluation of diagnostic tools, such as magnetic resonance imaging, for treatment guidance.
Main Results:
- Effective iron chelation requires targeting labile plasma iron to protect cells.
- Magnetic resonance imaging aids in personalizing chelation therapy by identifying preferential iron clearance sites.
- Achieving normal body iron levels may reduce the need for hormonal and cardiac interventions.
Conclusions:
- Current iron chelators offer varied benefits, safety profiles, and patient acceptance.
- Individualized treatment strategies are crucial for optimizing outcomes in thalassemia major.
- High-quality, long-term randomized clinical trials are necessary to further refine chelation therapy.
More Related Videos
05:36Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
1.0K
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
10.0K
Related Concept Videos
00:56Extraction: Advanced Methods
1.3K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.3K
01:19Complexation Equilibria: The Chelate Effect
1.6K
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
1.6K
01:28The Early Endosome: Endocytosis of Transferrin
5.2K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
5.2K
01:24Microbes and Other Elemental Cycles
61
Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...
61
02:51Metal-Ligand Bonds
25.6K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
25.6K
00:57The Periodic Table and Organismal Elements
205.7K
OverviewElements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally-occurring, and fewer still are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.The Periodic Table Provides Information...
205.7K